#ITI#Inhibition of Newcastle disease virus replication by lentivirus-mediated RNA interference#FTI#
#IRE#Small interfering RNA (siRNA)-induced RNA degradation can specifically inhibit viral infection and has been extensively investigated for its efficacy as an antiviral therapeutic approach. In this study we constructed a lentivirus vector carrying a U6-short hairpin RNA expression cassette to express siRNAs in vero cells. The lentivirus vector also expressed an enhanced green fluorescence protein as a reporter. Stable siRNA-expressing cell lines were successfully established, and the inhibition efficiencies of rationally designed siRNAs targeting conserved genomic regions of the Newcastle disease virus, an important disease of poultry world wide, were assessed. Our results showed that siRNAs targeting the nucleoprotein and matrix gene potently inhibited viral replication. Our study indicates that lentivirus-mediated delivery of siRNA and the resulting gene silencing can be used to study the functions of genes in viral replication and may have a potential transgenic antiviral application in poultry. © American Association of Avian Pathologists.#FRE#
#IPC#Antiviral application; Lentivirus vector; Small interfering RNA; Transgenic#FPC#
#IRF#Ahamed T., Hossain K.M., Billah M.M., Islam K.M.D., Ahasan M.M., Islam M.E., Adaptation of newcastle disease virus (ndv) on vero cell line, Inter. J. Poult. Sci, 3, pp. 153-156, (2004); 
Alexander D., Newcastle Disease and Other Avian Paramyxoviridae Infections Diseases of Poultry, pp. 541-569, (1997); 
Alexander D.J., The epidemiology and control of avian influenza and newcastle disease, J. Comp. Pathol, 112, pp. 105-126, (1995); 
Baba K., Goto-Koshino Y., Mizukoshi F., Setoguchi-Mukai A., Fujino Y., Ohno K., Tsujimoto H., Inhibition of the replication of feline immunodeficiency virus by lentiviral vector-mediated RNA interference in feline cell lines, J. Vet. Med. Sci, 70, pp. 777-783, (2008); 
Blomer U., Naldini L., Kafri T., Trono D., Verma I.M., Gage F.H., Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector, Journal of Virology, 71, 9, pp. 6641-6649, (1997); 
Case S.S., Price M.A., Jordan C.T., Yu X.J., Wang L., Bauer G., Haas D.L., Xu D., Stripecke R., Naldini L., Kohn D.B., Crooks G.M., Stable transduction of quiescent CD34<sup>+</sup>CD38<sup>-</sup> human hematopoietic cells by HIV-1-based lentiviral vectors, Proceedings of the National Academy of Sciences of the United States of America, 96, 6, pp. 2988-2993, (1999); 
Chambers P., Millar N.S., Bingham R.W., Emmerson P.T., Molecular cloning of complementary DNA to Newcastle disease virus, and nucleotide sequence analysis of the junction between the genes encoding the haemagglutinin-neuraminidase and the large protein, Journal of General Virology, 67, 3, pp. 475-486, (1986); 
Chen Y., Cheng G., Mahato R.I., RNAi for treating hepatitis B viral infection, Pharm. Res, 25, pp. 72-86, (2008); 
Deng L., Li G., Xi L., Yin A., Gao Y., You W., Wang X., Sun B., Hepatitis B virus inhibition in mice by lentiviral vector mediated short hairpin RNA, BMC Gastroenterol, 9, (2009); 
Dieckhoff B., Karlas A., Hofmann A., Kues W.A., Petersen B., Pfeifer A., Niemann H., Kurth R., Denner J., Inhibition of porcine endogenous retroviruses (PERVs) in primary porcine cells by RNA interference using lentiviral vectors, Archives of Virology, 152, 3, pp. 629-634, (2007); 
Elbashir S.M., Harborth J., Lendeckel W., Yalcin A., Weber K., Tuschl T., Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells, Nature, 411, 6836, pp. 494-498, (2001); 
Elbashir S.M., Harborth J., Weber K., Tuschl T., Analysis of gene function in somatic mammalian cells using small interfering RNAs, Methods, 26, 2, pp. 199-213, (2002); 
Elbashir S.M., Lendeckel W., Tuschl T., RNA interference is mediated by 21- and 22-nucleotide RNAs, Genes and Development, 15, 2, pp. 188-200, (2001); 
Fechner H., Pinkert S., Wang X., Sipo I., Suckau L., Kurreck J., Dorner A., Sollerbrant K., Zeichhardt H., Grunert H.-P., Vetter R., Schultheiss H.-P., Poller W., Coxsackievirus B3 and adenovirus infections of cardiac cells are efficiently inhibited by vector-mediated RNA interference targeting their common receptor, Gene Therapy, 14, 12, pp. 960-971, (2007); 
Gu W., Putral L., Hengst K., Minto K., Saunders N.A., Leggatt G., McMillan N.A.J., Inhibition of cervical cancer cell growth in vitro and in vivo with lentiviral-vector delivered short hairpin RNA targeting human papillomavirus E6 and E7 oncogenes, Cancer Gene Therapy, 13, 11, pp. 1023-1032, (2006); 
Jang J., Hong S.H., Kim I.H., Validation of a real-Time rtpcr method to quantify newcastle disease virus (ndv) titer and comparison with other quantifiable methods, J. Microbiol. Biotechnol, 21, pp. 100-108, (2011); 
Kim Y.J., Ahn J., Jeung S.Y., Kim D.S., Na H.N., Cho Y.J., Yun S.H., Jee Y., Jeon E.S., Lee H., Nam J.H., Recombinant lentivirusdelivered short hairpin RNAs targeted to conserved coxsackievirus sequences protect against viral myocarditis and improve survival rate in an animal model, Virus Genes, 36, pp. 141-146, (2008); 
Kumar P., Lee S.K., Shankar P., Manjunath N., A single siRNA suppresses fatal encephalitis induced by two different flaviviruses, PLoS Med, 3, (2006); 
Lamb R.A., Collins P.L., Kolakofsky D., Melero J.A., Nagai Y., Oldstone M.B.A., Pringle C.R., Rima B.K., Virus taxonomy: The classification and nomenclature of viruses, Eighth Report of the International Committee on Taxonomy of Viruses, pp. 655-668, (2005); 
Letellier C., Burny A., Meulemans G., Construction of a pigeonpox virus recombinant: Expression of the newcastle disease virus (ndv) fusion glycoprotein and protection of chickens against ndv challenge, Arch. Virol, 118, pp. 43-56, (1991); 
Livak K.J., Schmittgen T.D., Analysis of relative gene expression data using real-time quantitative PCR and the 2<sup>-ΔΔC</sup>T method, Methods, 25, 4, pp. 402-408, (2001); 
Nagai Y., Klenk H.D., Rott R., Proteolytic cleavage of the viral glycoproteins and its significance for the virulence of newcastle disease virus, Virology, 72, pp. 494-508, (1976); 
Overhoff M., Alken M., Far R.K.-K., Lemaitre M., Lebleu B., Sczakiel G., Robbins I., Local RNA target structure influences siRNA efficacy: A systematic global analysis, Journal of Molecular Biology, 348, 4, pp. 871-881, (2005); 
Panshin A., Shihmanter E., Weisman Y., Orvell C., Lipkind M., Antigenic epitope characterization of matrix protein of Newcastle disease virus using monoclonal antibody approach: Contrasting variability amongst NDV strains, Comparative Immunology, Microbiology and Infectious Diseases, 20, 2, pp. 177-189, (1997); 
Peeters B.P., Gruijthuijsen Y.K., De Leeuw O.S., Gielkens A.L., Genome replication of Newcastle disease virus: Involvement of the rule-of-six, Arch. Virol, 145, pp. 1829-1845, (2000); 
Pham H.M., Chang K.S., Mase M., Ohashi K., Onuma M., Molecular characterization of the nucleocapsid protein gene of Newcastle disease virus strains in Japan and development of a restriction enzyme-based rapid identifying method, Archives of Virology, 149, 8, pp. 1559-1569, (2004); 
Putral L.N., Bywater M.J., Gu W., Saunders N.A., Gabrielli B.G., Leggatt G.R., McMillan N.A.J., RNA interference against human papillomavirus oncogenes in cervical cancer cells results in increased sensitivity to cisplatin, Molecular Pharmacology, 68, 5, pp. 1311-1319, (2005); 
Schubert S., Grunweller A., Erdmann V.A., Kurreck J., Local RNA target structure influences siRNA efficacy: Systematic analysis of intentionally designed binding regions, Journal of Molecular Biology, 348, 4, pp. 883-893, (2005); 
Seal B.S., King D.J., Bennett J.D., Characterization of Newcastle disease virus isolates by reverse transcription PCR coupled to direct nucleotide sequencing and development of sequence database for pathotype prediction and molecular epidemiological analysis, J. Clin. Microbiol, 33, pp. 2624-2630, (1995); 
Singh S.K., Hajeri P.S.B., Sirnas: Their potential as therapeutic agents-part ii methods of delivery, Drug Discov. Today, 14, pp. 1-7, (2009); 
Sui H.Y., Zhao G.Y., Huang J.D., Jin D.Y., Yuen K.Y., Zheng B.J., Small interfering RNA targeting m2 gene induces effective and long term inhibition of influenza A virus replication, PLoS One, 4, (2009); 
Takimoto T., Portner A., Molecular mechanism of paramyxovirus budding, Virus Research, 106, SPEC.ISS. 2, pp. 133-145, (2004); 
Ter Brake O., Berkhout B., Lentiviral vectors that carry anti-HIV shRNAs: Problems and solutions, Journal of Gene Medicine, 9, 9, pp. 743-750, (2007); 
Tran J., Kung S.K.P., Lentiviral vectors mediate stable and efficient gene delivery into primary murine natural killer cells, Molecular Therapy, 15, 7, pp. 1331-1339, (2007); 
Ui-Tei K., Naito Y., Takahashi F., Haraguchi T., Ohki-Hamazaki H., Juni A., Ueda R., Saigo K., Guidelines for the selection of highly effective siRNA sequences for mammalian and chick RNA interference, Nucleic Acids Research, 32, 3, pp. 936-948, (2004); 
Xu M., Chang S., Ding Z., Gao H.W., Wan J.Y., Liu W.S., Liu L.N., Gao Y., Xu. J., Genomic analysis of Newcastle disease virus strain NA-1 isolated from geese in China, Arch. Virol, 153, pp. 1281-1289, (2008); 
Yin R., Ding Z., Liu X., Mu L., Cong Y., Stoeger T., Inhibition of newcastle disease virus replication by rna interference targeting the matrix protein gene in chicken embryo fibroblasts, J. Virol. Methods, 167, pp. 107-111, (2010); 
Yue H., Deng S., Yang F.L., Li D.F., Fu A.J., Yang F., Tang C., Short hairpin rna targeting np mrna inhibiting newcastle disease virus production and other viral structural mrna transcription, Virus Genes, 38, pp. 143-148, (2009); 
Zhou H., Jin M., Yu Z., Xu X., Peng Y., Wu H., Liu J., Liu H., Cao S., Chen H., Effective small interfering RNAs targeting matrix and nucleocapsid protein gene inhibit influenza A virus replication in cells and mice, Antiviral Research, 76, 2, pp. 186-193, (2007)#FRF#
